Effect of Lifitegrast 5% on Tear Film Markers

PHASE4WithdrawnINTERVENTIONAL

Timeline

Start Date

March 1, 2021

Primary Completion Date

December 31, 2021

Study Completion Date

December 31, 2021

Conditions

Dry EyeDry Eye SyndromesDry Eyes Chronic

Interventions

DRUG

Lifitegrast 5% Ophthalmic Solution

Participants will received lifitegrast 5% ophthalmic solution twice a day in each eye for approximately 4 weeks.

Trial Locations (1)

Weill Cornell Ophthalmology, New York